Aciphex
Drug
Eisai Co., Ltd.
Total Payments
$46,215
Transactions
777
Doctors
554
Companies
5
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $2,160 | 131 | 112 |
| 2020 | $40,390 | 559 | 402 |
| 2019 | $3,664 | 87 | 87 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,563 | 4 | 72.6% |
| Food and Beverage | $12,652 | 773 | 27.4% |
Ad
Manufacturing Companies
- Eisai Inc. $31,673
- Aytu Bioscience, Inc $8,718
- Aytu BioPharma, Inc. $2,160
- Eisai Co., Ltd. $1,890
- Aytu BioScience, Inc $1,774
Product Information
- Type Drug
- Total Payments $46,215
- Total Doctors 554
- Transactions 777
About Aciphex
Aciphex is a drug associated with $46,215 in payments to 554 healthcare providers, recorded across 777 transactions in the CMS Open Payments database. The primary manufacturer is Eisai Co., Ltd..
Payment data is available from 2019 to 2021. In 2021, $2,160 was paid across 131 transactions to 112 doctors.
The most common payment nature for Aciphex is "Consulting Fee" ($33,563, 72.6% of total).